AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma	Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm	Recruiting	Phase 2	2026-07-14		NCT05669339

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Sun Pharmaceutical Industries Ltd	1
University of Florida	315

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Florida	Gainesville	United States	144

Clinical trials